Zynerba Pharmaceuticals
Get Full AccessDescription
- Zynerba Pharmaceuticals (NASDAQ:ZYNE) is a clinical-stage specialty pharmaceutical company focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Zynerba is developing therapeutic candidates based on proprietary transdermal technologies that, if successfully developed, may allow sustained, consistent and controlled delivery of therapeutic levels of two cannabinoids: cannabidiol (CBD), a non-psychoactive cannabinoid, and tetrahydrocannabinol (THC). Transdermal delivery has the potential to reduce adverse effects associated with oral dosing. ZYN002, the Companys CBD gel, is the first and only synthetic CBD formulated as a patent-protected permeation-enhanced gel. In June 2016, the company initiated the Phase 2 STAR 1 (Synthetic Transdermal Cannabidiol for the Treatment of Epilepsy) clinical trial of ZYN002 CBD gel in refractory epilepsy patients with focal seizures, the most common form of epilepsy in adults. In August 2016, the Phase 2 STOP (Synthetic Transdermal Cannabidiol for the Treatment of Knee Pain due to Osteoarthritis) clinical trial in patients with knee pain due to osteoarthritis was initiated. In December 2016, the Company initiated the exploratory Phase 2 FAB-C (Treatment of Fragile X Syndrome Anxiety and Behavioral Challenges with CBD) clinical trial in children with Fragile X syndrome (FXS).Zynerba is also developing ZYN001, which utilizes a synthetically manufactured pro-drug of THC. A Phase 1 clinical study for ZYN001 is planned to begin in the first half of 2017. Learn more at www.zynerba.com and follow the Company on Twitter at @ZynerbaPharma.
-
Headquarters:80 West Lancaster Avenue Suite 300, Devon, Pennsylvania, United States
More -
Phone Number: +1 484-581-7505
-
Website: https://www.zynerba.com
-
Employees:31
-
Revenue:$1 - 10M
-
Legal Name:Zynerba Pharmaceuticals
-
Zynerba Pharmaceuticals's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Zynerba Pharmaceuticals
-
Where are Zynerba Pharmaceuticals's Headquarters?
Zynerba Pharmaceuticals's Headquarters are in 80 West Lancaster Avenue Suite 300,Devon,Pennsylvania,United States
-
What is Zynerba Pharmaceuticals's phone number?
Zynerba Pharmaceuticals's phone number is +1 484-581-7505
-
What is Zynerba Pharmaceuticals's official website?
Zynerba Pharmaceuticals's official website is https://www.zynerba.com
-
What is Zynerba Pharmaceuticals's Revenue?
Zynerba Pharmaceuticals's revenue is $1 - 10M
-
What is Zynerba Pharmaceuticals's NAICS code?
Zynerba Pharmaceuticals's NAICS code is 325412
-
How many employees are working in Zynerba Pharmaceuticals
Zynerba Pharmaceuticals has 31 employees
-
What is Zynerba Pharmaceuticals's Industry?
Zynerba Pharmaceuticals is in the industry of Pharmaceuticals
-
Who is Zynerba Pharmaceuticals's CEO?
Zynerba Pharmaceuticals's CEO is Armando Anido